Back to Journals » Patient Preference and Adherence » Volume 13

The role of technology in the management of Diabetes mellitus [Letter]

Authors Khan IH , Bilal AR 

Received 9 July 2019

Accepted for publication 13 July 2019

Published 1 August 2019 Volume 2019:13 Pages 1335—1336

DOI https://doi.org/10.2147/PPA.S222494

Checked for plagiarism Yes

Editor who approved publication: Dr Johnny Chen



Inayat Hussain Khan, Azhar Ramzan Bilal

Faculty of Medicine, St George’s Hospital Medical School, London, UK

We read this article by Khurana et al1 with great interest. It is encouraging to see a study which explored how adherence in patients with Type 2 Diabetes mellitus could potentially be improved.

Diabetes is a condition affecting an increasing number of people and the macrovascular and microvascular changes are damaging to long term health, predisposing to vascular events such as heart attacks and strokes.Adherence to treatment plans is essential for good glycaemic control and to prevent such complications. A study found that effective communication between doctors and patients is key to ensuring adherence to individual treatment plans but of course this does not always take place.3 This current study1 evaluated how technology can help to bridge this gap in the management of chronic conditions like diabetes where treatment is lifelong and complex. Khurana et al1 showed that there is an appetite amongst patients for better use of technology to help manage chronic conditions; more than 80% of the participants surveyed in this study
were interested in using electronic methods to assist them in managing their diabetes.

Read the original article by Khurana and collegues here

Dear editor

We read this article by Khurana et al1 with great interest. It is encouraging to see a study which explored how adherence in patients with Type 2 Diabetes mellitus could potentially be improved.

Diabetes is a condition affecting an increasing number of people and the macrovascular and microvascular changes are damaging to long term health, predisposing to vascular events such as heart attacks and strokes.2

Adherence to treatment plans is essential for good glycaemic control and to prevent such complications. A study found that effective communication between doctors and patients is key to ensuring adherence to individual treatment plans but of course this does not always take place.3 This current study1 evaluated how technology can help to bridge this gap in the management of chronic conditions like diabetes where treatment is lifelong and complex. Khurana et al1 showed that there is an appetite amongst patients for better use of technology to help manage chronic conditions; more than 80% of the participants surveyed in this study were interested in using electronic methods to assist them in managing their diabetes.

Despite these promising findings, we have identified some limitations that need to be addressed in order to assess the applicability of technology in the management of chronic conditions. For instance, we note that the recruitment of participants for this study was done through advertisements online and on newspapers. This may have introduced selection bias into this sample, as individuals who respond to such advertisements are more likely to be conscious about their health and positive about the use of technology and this may be reflected in the results.

Similarly, these advertisements through newspapers and through the internet are more likely to exclude those with limited English proficiency (LEP). In the US, Latinos make up the largest minority population and also make up a huge proportion of those with LEP. Steinberg et al4 evaluated 48 interviews of Latina mothers with LEP and found that navigating the healthcare system for these individuals can be a “battle” and is one of the reasons for huge inequalities in healthcare provision. It is therefore imperative that the use of technology such as apps does not create further inequalities in healthcare provision.

There are 318,000 apps available to help individuals manage their own health. 5 Thus, shifting the role of doctors and other primary care staff such as specialist diabetic nurses to these smartphone platforms can seem tempting and even a sign of patient empowerment. Although this study highlights some positive attitudes to technology in managing diabetes it is important that this approach is suitable for a wide range of patients including those with LEP.

We, therefore, argue that to properly measure the applicability of technology in primary care settings, future studies should take these potential sources of selection bias into consideration and recruit through various outlets and possibly even at point of care to ensure that the views of a representative population including those with LEP are taken into account.

Disclosure

The authors report no conflicts of interest in this communication.

References

1. Khurana L, Durand E, Gary S, et al. Mechanisms for improving diabetes patient–provider communication through optimal use of e-clinical technologies. Patient Preference and Adherence. 2019;13:981–992. doi:10.2147/PPA.S207008

2. Chen R, Ovbiagele B, Feng W. Diabetes and stroke: epidemiology, pathophysiology, pharmaceuticals and outcomes. The American Journal of the Medical Sciences. 2016;351(4):380–386. doi:10.1016/j.amjms.2016.01.011

3. Haskard Zolnierek K, DiMatteo M. Physician communication and patient adherence to treatment: a meta-analysis. Medical Care. 2009;47(8):826–834. doi:10.1097/MLR.0b013e31819a5acc

4. Steinberg E, Valenzuela-Araujo D, Zickafoose J, Kieffer E, DeCamp L. The “battle” of managing language barriers in health care. Clinical Pediatrics. 2016;55(14):1318–1327. doi:10.1177/0009922816629760

5. Aitken M, Clancey B, Nass D The Growing Value of Digital Health. New Jersey, USA: IQVIA Institute for Human Data Science; 2017. [2019–06–28]. Evidence and Impact on Human Health and the Healthcare System. Available from: https://www.iqvia.com/institute/reports/the-growing-value-of-digital-health. Accessed 28 June, 2019.

Creative Commons License © 2019 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.